Title: Oral Manifestation of Respiratory Disorder -A Review
Author: Aishwarya.J
DOI: http://dx.doi.org/10.18535/jmscr/v4i8.59
Abstract
Many pulmonary disorders like respiratory obstructive diseases, systemic diseases with pulmonary involvement, lung cancer, cystic fibrosis or tuberculosis all have clinical and/ or therapeutic involvement of the oral cavity, which underlines the necessity of regular dental services and careful oral cavity exam, as well as an active collaboration between dental practitioners and pulmonologists. The main objective of this review is to create awareness among the dental professionals about the various oral manifestations of respiratory disorders, so that they diagnose it in a much earlier stages, for patient’s ultimate benefit
KEY WORDS: Pulmonary disorders, dental service, oral cavity,
References
1. Poul Erik Petersen,Denis Bourgeois, Hiroshi Ogawa, Saskia Estupinan-Day, & Charlotte Ndiaye. The global burden of oral diseases and risks to oral health. Bulletin of the World Health Organization ,September 2005, 83 (9)
2. Oral Diseases and Other Systemic Conditions. Washington state department of health. DOH 160-001 July 2007
3. Comprehensive respiratory medicine. London: Albert R, Spiro S, Jett J. Mosby Inc.; 1999.
4. Doina-Clementina Cojocaru, Andrei Georgescu, Robert D.Negru. Oral manifestations in pulmonary diseases- too often a neglected problem. International journal of medical dentistry
5. Baltch, A. L., H. L. Pressman, C. Schaffer, R. P. Smith, M. C. Hammer, M.Shayegani, and P. Michelsen. 1988. Bacteremia in patients undergoing prophylaxis as recommended by the American Heart Association, 1977. Arch. Intern. Med. 148:1084–1088
6. Carroll, G. C., and R. J. Sebor. 1980. Dental flossing and its relationship to transient bacteremia. J. Periodontol. 51:691–692
7. Ebelian, G. J., I. Olsen, and L. Tronstad. 1995. Bacteremia in conjunction with endodontic therapy. Endod. Dent. Traumatol. 11:142–149.
8. Donley, T. G., and K. B. Donley. 1988. Systemic bacteremia following toothbrushing: a protocol for management of patients susceptible to infective endocarditis. Gen. Dent. 36:482–484.
9. Drinnan, A. J., and C. Gogan. 1990. Bacteremia and dental treatment.J. Am. Dent. Assoc. 120:378.
10. Heimdahl, A., G. Hall, M. Hedberg, H. Sandberg, P. O. Soder, K. Tuner, and C. E. Nord. 1990. Detection and quantitation by lysis-filtration of bacteremia after different oral surgical procedures. J. Clin. Microbiol. 28: 2205–2209.
11. Little, J. W. 1991. Prosthetic implants: risk of infection from transient dental bacteremia. Compendium 12:160–164.
12. Lofthus, J. E., M. Y. Waki, D. L. Jolkovsky, J. Otomo-Corgel, M. G. Newman, T. Flemmig, and S. Nachnani. 1991. Bacteremia following subgingival irrigation and scaling and root planing. J. Periodontol. 62:602–607.
13. Navazesh, M., and R. Mulligan. 1995. Systemic dissemination as a result of oral infection in individuals 50 years of age and older. Spec. Care Dentist.15:11–19.
14. Okabe, K., K. Nakagawa, and E. Yamamoto. 1995. Factors affecting the occurrence of bacteremia associated with tooth extraction. Int. J. Oral Maxillofac. Surg. 24:239–242.
15. Kilian, M. 1982. Systemic disease: manifestations of oral bacteria, p. 832–838. In J. R. McGhee, S. M. Michalek, and G. H. Cassell (ed.), Dental microbiology. Harpers & Row, Philadelphia, Pa.
16. Loesche, W. J. 1994. Ecology of the oral flora, p. 307–319. In R. J. Nisengardand M. G. Newman (ed.), Oral microbiology and immunology, 2nd ed. W. B. Saunders, Philadelphia, Pa.
17. Loesche, W. J., and D. E. Lopatin. 1998. Interactions between periodontal disease, medical diseases and immunity in the older individual. Periodontol. 2000 16:80–105.
18. Weinberg, A., S. Krisanaprakornkit, and B. A. Dale. 1998. Epithelial antimicrobial peptides: review and significance for oral applications. Crit. Rev. Oral Biol. Med. 9:399–414.
19. Loesche, W. J. 1994. Periodontal disease as a risk factor for heart disease. Compe-ndium 15:976, 978–982, 985–986 passim.
20. Christensen PJ, Kutty K, Adlam RT, Taft TA, Kampschroer BH. Septic pulmonary embolism due to periodontal disease. Chest 1993; 104(6):1927-9.
21. Morris JF, Sewell DL. Necrotizing pneumonia caused by mixed infection with Actinobacillus actinomycetemcomitans and Actinomyces israelii: case report and review. Clin Infect Dis 1994; 18(3):450-2.
22. Huxley EJ, Viroslav J, Gray WR, Pierce AK. Pharyngeal aspiration in normal adults and patients with depressed consciousness. Am J Med 1978; 64(4):564-8.
23. Philippe Mojon, DMD, PhD, Oral Health and Respiratory Infection. Journal of the Canadian Dental Association. June 2002, Vol. 68, No. 6
24. Haslett C, Chilvers ER, Corris P.A. Respiratory disease IN: Haslett christoper, Chilvers Edwin R, Boon Nicholas A, Colledge Nicki R. Davidson's principles and practice of medicine I9th ed. Churchill living stone: Edinburgh; 2002 : 508-513.
25. Dental Recommendations for Preventing Complications in Patients with Chronic Conditions Health Partners Research Foundation eDent Study.
26. SS,Rahman, M.Faruque, MHAKhan, SAHossain. Dental management of COPD patient.Bang Med J (Khulna) 2011; 44 : 21-24
27. Russell SL, Boylan RJ, Kaslick RS, Scannapieco FA, Katz RV.Respiratory pathogen colonization of the dental plaque of institutionalized elders. Spec Care Dentist 1999;19:128–34.
28. Scannapieco FA, Papandonatos GD, Dunford RG. Associations between oral conditions and respiratory disease in a national sample survey population. Ann Periodontol 1998;3:251–6.
29. Scannapieco FA, Ho AW. Potential associations between chronic respiratory disease and periodontal disease: analysis of national health and nutrition examinat-ion survey III. J Periodontol 2001;72:50–6
30. Hayes C, Sparrow D, Cohen M, Vokonas PS, Garcia RI. The association between alveolar bone loss and pulmonary function:the VA dental longitudinal study. Ann Periodontol 1998;3:257–61.
31. Persson GR, Ohlsson O, Pettersson T, Renvert S. Chronic periodontitis, a significant relationship with acute myocardial infarction. Eur Heart J 2003;24:2108–15.
32. Renvert S, Ohlsson O, Persson S, Lang NP, Persson GR. Analysis of periodontal risk profiles in adults with or without a history of myocardial infarction. J Clin Periodontol 2004;31:19–24.
33. Leuckfelda, M.V. Obregon-Whittlea, M.B. Lundb, O. Geiranc, Ø. Bjørtuftb, I. Olsena. Severe chronic obstructive pulmonary disease: Association with marginal bone loss in periodontitis. Respiratory Medicine (2008) 102, 488–494.
34. Leuckfeld I, Obregon-Whittle MV, Lund MB, Geiran O, Bjørtuft Ø, Olsen I. Severe chronic obstructive pulmonary disease: association with marginal bone loss in periodontitis. Respir Med 2008; 102: 488–494.
35. Hyman JJ, Reid BC. Cigarette smoking, periodontal disease: and chronic obstru-ctive pulmonary disease. J Periodontol 2004; 75: 9–15.
36. Wang Z, Zhou X, Zhang J, Zhang L, Song Y, Hu FB, Wang C. Periodontal health, oral health behaviours, and chronic obstructive pulmonary disease. J Clin Periodontol 2009; 36: 750–755.
37. Przybylowska D, Mierzwiñska-Nastalska E, Rubinsztajn R, Chazan R, Rolski D, Swoboda-Kopeæ E. Influence of denture plaque biofilm on oral mucosal membrane in patients with chronic obstructive pulmonary disease. Adv Exp Med Biol 2015; 839: 25-30.
38. Kornum JB, Svaerke C, Thomsen RW, Lange P, Sorensen HT. Chronic obstructive pulmonary disease and cancer risk: a Danish nationwide cohort study. Respir Med 2012; 106: 845-852.
39. Kolokotronis A, Antoniadis D, Trigonidis G, Papanagiotou P. Oral tuberculosis: Oral Dis 1996;2:242-3.
40. Mignogna MD, Muzio LLO, Favia G, et al.( 2000) Oral tuberculosis: a clinical evaluation of 42 cases. Oral Dis 6:25-30
41. Sezer B, Zeytinoglu M, Tuncay U, Unal T (2004) Oral mucosal ulceration: a manife-station of previously undiagnosed pulmonary tuberculosis. J Am Dent Assoc 135:336-40.
42. Hashimoto Y, Tanioka H (1989) Primary tuberculosis of the tongue: report of a case. J Oral Maxillofac Surg 47:744-46.
43. Aoun N, El-Haji G, El Toum S. Oral ulcer: an uncommon site in primary tuberculosis. Austral Dent J 2015; 60(1): 119
44. Singhaniya SB, Barpande SR, Bhavthankar JD. Oral tuberculosis in an asymptomatic pulmonary tuberculosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011; 111(3): e8-e10.
45. Sezer B, Zeytinoglu M, Tuncay U, Unal T. Oral mucosal ulceration: a manifestation of previously undiagnosed pulmonary tuberculosis. J Am Dent Assoc 2004; 135(4): 336-340.
46. Tubercular Palatal Perforation : First Clinical Sign of Undiagnosed Pulmonary Tuberculosis. Volume : 3 Issue : 8 Aug 2013 , ISSN - 2249-555X
47. Kamala R, Abhishek Sinha, Amitabh Srivastava1, Sunita Srivastava. Primary tuberculosis of the oral cavity. May 08, 2016, IP: 117.208.201.24
48. P. Mahesh Kumar , Capt. S. Manoj Kumar, Sonali Sarkar, S. Ramasubra-manian, K.J.Anu, L.Aravindh. Oral manifestations in patients with pulmonary tuberculosis. 2010 Bio Med Sci Direct Publications IJBMR -ISSN: 0976:6685
49. Ferrazzano GF, Orlando S, Sangianantoni G, Cantile T, Ingenito A. Dental and periodontal health status in children affected by cystic fibrosis in a southern Italian region. Eur J Ped Den 2009; 10(2): 65-68.
50. Gerald W. Fernald, MD Michael W. Roberts, DDS, MScD Thomas F. Boat, MD. Cystic fibrosis: a current review. PEDIATRICD ENTISTRY/Copyrigh©t 1990 by The AmericanA cademoy f Pediatric Dentistry Volume 12, Number 2.
51. Swallow JN, DeHaller J, Young WF: Side-effects to antibiotics in cystic fibrosis: dental changes in relation to antibiotic administration. Arch Dis Child 42:311-18, 1967.
52. Jagels AE, Sweeney EA: Oral health of patients with cystic fibrosis and their siblings. J Dent Res 55:991-96, 1976.
53. Mandel ID, Kutcher A, Denning CR, Thompson RH, Zegarelli EV: Salivary studies in cystic fibrosis. Am I Dis Child 113:431-38,1967.
54. Wiesmann UN, Boat TF, di Sant’Agnese PA: Flow-rates and electrolytes in minor salivary-gland saliva in normal subjects and patients with cystic fibrosis. Lancet II:510-12, 1972.
55. Wotman S, Mercadante J, Mandel ID, Goldman RS, Denning C: The occurance of calculus in normal children, children with cystic fibrosis, and children witb asthma. J Periodonto144:278-80, 1973.
56. Kinirons M J: Dental health of children with cystic fibrosis: an interim report. J Paediatr Dent 1:3-7, 1985.
57. Primosch RE: Tetracycline discoloration, enamel defects and dental caries in patients with cystic fibrosis. Oral Surg 50:301-308, 1980.
58. Littleton NW, White CL: Dental findings from a preliminary study of children receiving extended antibiotic therapy. J Am Dent Assoc 68:520-25, 1964.
59. Sweeney EA, Shaw IA: The effect of dietary pancreatin supplements on dental caries and on the composition of saliva in caries susceptible rats. J Dent Res 44:973-76, 1965.
60. Lindemann RA, Newman MG, Kaufman AK, LeTV: Oral colonization and susceptibility testing of Pseudomonas aeruginosa oral isolates from cystic fibrosis patients. J Dent Res 64:54-57, 1985.
61. Blacharsh C: Dental aspects of patients with cystic fibrosis: a preliminary clinical study. J Am Dent Assoc 95:106-110, 1977.
62. ICD 9 code 493.2
63. Thomas MS, Parolia A, Kundabala M, Vikram M. Astma and oral health: a review. Austral Dent J 2010; 55: 128-133. doi: 10.1111/j.1834- 7819.2010.001226.x
64. Ryberg M, Moller C, Ericson T. Saliva composition and caries development in asthmatic patients treated with beta-2 adrenoceptor agonists: a 4-year follow-up study. Scand J Dent Res 1991; 99: 212-218.
65. Kuo LC, Polson AM, Kang T. Associations between periodontal diseases and systemic diseases: a review of the inter-relationships and interactions with diabetes, respiratory diseases, cardiovascular diseases and osteoporosis. Public Health 2008; 12: 417-433.
66. Stensson M, Wendt LK, Koch G, Oldaeus G, Birkhed D. Oral health in preschool children with asthma. Int J Paediatr Dent 2008; 18: 243-250.
67. Arbes SJ, Matsui EC. Can oral pathogens influence allergic disease? J Allergy Clin Immunol 2011; 127: 1119-1127.
68. Card JW, Carey MA, Voltz JW, Bradbury A, Ferguson CD, Cohen EA, Schwartz S, Flake GP, Morgan DL, Arbes SJ, Barrow DA, Barros SP, Offenbacher S, Zeldin DC. Modulation of allergic airway inflamma-tion bt the oral pathogen Porphyromonas gingivalis. Infect Immunol 2010; 78(6): 2488-2496. doi:10.1128/IAI.01270-09
69. Arbes SJ Jr, Sever ML, Vaughn B, Cohen EA, Zeldin DC. Oral pathogens and allergic disease: results from the Third National Health and Nutrition Examination Survey. J Allergy Clin Immunol 2006; 118: 1169-1175.
70. Xiaojing LI, Krishtin M, Kolltveit, Leif Tronstad and Ingar Olsen. Systemic Diseases Caused by Oral Infection. Clinical microbiological review , 0893-8512/00/$04.0010 Oct. 2000, p. 547–558 Vol. 13, No. 4
71. Donowitz, G. R., and G. L. Mandell. 1990. Acute pneumonia, p. 540–555. In G. L. Mandell, R. G. Douglas, and J. E. Bennett (ed.), Principles and practice of infectious diseases. Churchill Livingstone, New York, N.Y.
72. Levison, M. E. 1994. Pneumonia, including necrotizing pulmonary infections (lung abscess), p. 1184–1191. In K. J. Isselbacher, E. Braunwald, and J. D. Wilson (ed.), Harrison’s principles of internal medicine. McGraw-Hill, New York, N.Y.
73. Scannapieco, F. A., and J. M. Mylotte. 1996. Relationships between periodontal disease and bacterial pneumonia. J. Periodontol. 67:1114–1122.
74. Bonten, M. J., C. A. Gaillard, F. H. van Tiel, H. G. Smeets, S. van der Geest, and E. E. Stobberingh. 1994. The stomach is not a source for colonization of the upper respiratory tract and pneumonia in ICU patients. Chest 105:878–884.
75. Scannapieco, F.A. G.D.Papandonatos, and R. G. Dunford. 1998. Associations between oral conditions and respiratory disease in a national sample survey population. Ann. Periodontol. 3:251–256.
76. Limeback, H. 1988. The relationship between oral health and systemic infections among elderly residents of chronic care facilities. Gerodontology 7:131–137.
77. Loesche, W. J., and D. E. Lopatin. 1998. Interactions between periodontal disease, medical diseases and immunity in the older individual. Periodontol. 2000 16:80–105.
78. Suresh L, Radfar L. Oral sarcoidosis: a review of literature. Oral Diseases 2005; 11: 138-145.
79. James DG, Sharma OP. Parotid gland sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2000; 17: 27-32.
80. Mandel L, Kaynar A. Sialadenopathy: a clinical herald of sarcoidosis. J Oral Maxillofac Surg 1994; 52: 1208-1210.
81. Kaugars GE, Svirsky JA. Lung maligna-ncies metastatic to the oral cavity. Or Surg Or Med Or Pa 1981; 51(2): 179-186.
82. Maiorano E, Piatelli A, Favia G. Hepatocellular carcinoma metastatic to the oral mucosa: report of a case with multiple gingival localizations. J Periodontal 2000; 71: 641-645.
83. Godara N, Godara R, Khullar M. Impact of inhalation therapy on oral health. Lung India 2011; 28: 272-275.
84. Buhl R. Local oropharyngeal side effects of inhaled corticosteroids in patients with asthma. Allergy 2006; 61: 518-526.
85. Kelly HW, Nelson HS. Potential adverse effects of the inhaled corticosteroids. J Allergy Clin Immunol 2003; 112: 469-478.
86. Casiglia JM, Elston DM. Oral manifestations of systemic diseases. Medscape reference, http://emedicine.medscape.com/article/1081029-overview, Accessed October 6, 2014.122
87. McDerra EJ, Bjerkeborn K, Dahllof G, Hedlin G, Lindell M, Modeer T. Effect of disease severity and pharmacotherapy of asthma on oral health in asthmatic child-ren. Scand J Dent Res 1988; 22: 297-301.